Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKooth Plc Regulatory News (KOO)

Share Price Information for Kooth Plc (KOO)

Share Price is delayed by 15 minutes
Get Live Data
166.00    -2.00 (-1.19%)
Bid:
162.00
Ask:
170.00
Spread: 8.00 (4.938%)
Market Cap: £60.21m
KOO Live PriceLast checked at - London Stock Exchange

Intraday Kooth Plc Share Chart

Directorate Change

19 May 2026 07:00

RNS Number : 7982E
Kooth PLC
19 May 2026
 

19 May 2026

 

Kooth Plc

("Kooth", the "Company" or the "Group")

 

Directorate Change

 

Kooth (AIM: KOO), a leading provider of digital mental health services, is pleased to announce the appointment of James A. Polo as an independent Non-Executive Director with immediate effect.

 

James A. Polo brings over 25 years of experience across provider, payer and government sectors in the United States, combining distinguished clinical expertise as a board-certified child and adolescent psychiatrist with extensive corporate leadership in behavioural health strategy and operations. James currently serves as Chief Medical Officer for United Healthcare of Washington state, where he supports in aligning strategy, operations and performance across the Washington Medicaid plan. Previously, he served as Chief Medical Officer at Carelon Behavioral Health, part of Elevance Health, where he led the national behavioural health strategy across all 50 states for approximately 96 million members. Prior to this, James held senior roles at Cambia Health Solutions, including Chief Medical Officer for the Oregon market.

 

James has maintained active clinical practice throughout his career as a child and adolescent psychiatrist, with extensive experience in paediatric mental health delivery networks. James holds numerous leadership positions, including governance roles with the American Psychiatric Association.

 

Kate Newhouse, CEO of Kooth, said:

"We are delighted to welcome James to the Board as a Non-Executive Director. James brings exceptional expertise in behavioural health, combining deep clinical experience as a child and adolescent psychiatrist with extensive corporate leadership across the complex US healthcare landscape. His understanding of payer dynamics, Medicaid systems and government policy, alongside his passion for early intervention and technology-enabled solutions for young people, aligns perfectly with Kooth's mission and growth strategy. His insights will strengthen our Board as we continue to expand our presence in the United States."

 

Enquiries:

 

Kooth plc

investorrelations@kooth.com

Peter Whiting, Chairman

Kate Newhouse, CEO

Sanjay Jawa, CFO

 

Stifel, Nominated Adviser & Joint Broker

+44 (0) 20 7710 7600

Ben Maddison, Fred Walsh, Erik Anderson, Ben Good

Canaccord Genuity, Joint Broker

+44 (0)20 7523 8000

Simon Bridges, Harry Gooden, Elizabeth Halley-Stott

FTI Consulting, Financial PR

Kooth@fticonsulting.com

Ben Atwell, Sam Purewal, Lucy Molloy

 

About Kooth plc:

Kooth (AIM:KOO) is a global leader in digital mental and behavioural health, providing safe, effective care to over 20 million people across the UK and US. For more than 20 years, Kooth has pioneered scalable solutions that deliver immediate, direct, universal access to mental health support.

 

Our platforms - Kooth, Qwell, and Soluna - combine self-guided tools, safe peer communities, and professional therapeutic support, all clinically robust and independently accredited. Kooth holds URAC accreditation in the US and is the longest standing digital mental health provider to hold UK-wide accreditation from the British Association of Counselling and Psychotherapy (BACP), validating our commitment to quality, safety, and accountability across both markets.

 

Independent evaluations demonstrate a £3 return for every £1 invested, with measurable reductions in emergency visits and improved clinical outcomes. Kooth is the largest single access provider for mental health support for under-18s in England according to NHS England data for 2024/25. In California, our Soluna platform is the first statewide digital behavioural health solution designed for all youth ages 13-25.

 

The Company is executing on its strategic vision through expanded reach across a diversified customer base, while seeking opportunities to enhance and extend the service offer through acquisition, partnership, and product capabilities supported by responsible AI principles.

 

 For more information, https://investors.kooth.com

 

Regulatory disclosures - The following disclosures are made in accordance with Schedule 2(g) of the AIM Rules for Companies: James Alan Polo, aged 65, holds no ordinary shares or options in the Company. James's current and previous directorships are as follows:

 

Current Directorships

Previous Directorships (last 5 years)

Washington Chapter of the American Academy of Paediatrics

James A. Polo MD PLLC

Kathleen B. Polo MD PLLC

Harbor Stones Marina, LLC

Fora Health, Inc.

 

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGMKVRVGVZM
Date   Source Headline
19th May 20267:00 amRNS2025 Annual Report and Notice of 2026 AGM
19th May 20267:00 amRNSDirectorate Change
20th Apr 20267:00 amRNS-R2025 Impact Report Shows Soluna's Continued Growth
8th Apr 20267:00 amRNS2025 Full Year Results
19th Mar 20267:00 amRNSNotice of Full Year Results
12th Mar 20269:19 amRNSTransfer of Treasury Shares & Exercise of Options
2nd Mar 202610:57 amRNSTransfer of Treasury Shares & Exercise of Options
2nd Mar 20267:00 amRNSBlock Listing Six Monthly Return
11th Feb 20265:51 pmRNSAwards under LTIP and PDMR dealing
2nd Feb 202612:48 pmRNSTransfer of Treasury Shares & Exercise of Options
28th Jan 20267:00 amRNSTrading Update
22nd Jan 20267:05 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNS$2.6m contract win with new US State
17th Dec 202510:02 amRNSTransfer of Treasury Shares & Exercise of Options
4th Dec 20253:26 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNS-RKooth Acquires US Telehealth Platform
11th Nov 20257:00 amRNSTransfer of Treasury Shares & Exercise of Options
10th Oct 20252:30 pmRNSHolding(s) in Company
2nd Oct 20257:00 amRNSKooth renews New Jersey contract
24th Sep 20253:55 pmRNSHolding(s) in Company
23rd Sep 20257:00 amRNSUnaudited Half Year Results
4th Sep 20257:00 amRNSTransfer of Treasury Shares & Exercise of Options
29th Aug 20257:00 amRNSBlock Listing Six Monthly Return
8th Aug 20257:00 amRNSAppointment of Joint Corporate Broker
1st Aug 20257:00 amRNSTransfer of Treasury Shares & Exercise of Options
28th Jul 20257:00 amRNSHalf Year Trading and Operational Update
1st Jul 20257:00 amRNSKooth welcomes report on California Soluna data
27th Jun 20253:51 pmRNSHolding(s) in Company
24th Jun 20251:12 pmRNSResult of 2025 Annual General Meeting
3rd Jun 20259:32 amRNSHolding(s) in Company
23rd May 20254:06 pmRNSAwards - Long Term Incentive Plan and PDMR dealing
14th May 20257:00 amRNSAnnual Financial Report
15th Apr 20257:00 amRNSFull Year Results
31st Mar 20251:00 pmRNSHolding in Company
28th Feb 20257:00 amRNSBlock Listing Six Monthly Return
13th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20255:53 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.